Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

  1. Home
  2. Development And Optimization Of A Bladder Cancer Algorithm Using Seer-medicare Claims Data
  1. Home
  2. Development And Optimization Of A Bladder Cancer Algorithm Using Seer-medicare Claims Data

Related Experiment Video

Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors
05:19

Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors

Published on: March 29, 2019

10.3K

Development and Optimization of a Bladder Cancer Algorithm Using SEER-Medicare Claims Data

John L Gore1, Phoebe Wright2, Vanessa Shih2

  • 1University of Washington, Seattle, WA.

JCO Clinical Cancer Informatics
|September 19, 2024

View abstract on PubMed

Summary
This summary is machine-generated.

A new algorithm accurately categorizes bladder cancer (BC) patients into non-muscle-invasive (NMIBC), muscle-invasive (MIBC), and advanced stages using healthcare claims data. This tool aids researchers in staging BC for administrative claims-based studies.

More Related Videos

An Orthotopic Bladder Cancer Model for Gene Delivery Studies
07:48

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

12.4K
Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

6.7K

Related Experiment Videos

Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors
05:19

Magnetic Resonance Imaging Assessment of Carcinogen-induced Murine Bladder Tumors

Published on: March 29, 2019

10.3K
An Orthotopic Bladder Cancer Model for Gene Delivery Studies
07:48

An Orthotopic Bladder Cancer Model for Gene Delivery Studies

Published on: December 1, 2013

12.4K
Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

6.7K

Area of Science:

  • Oncology
  • Health Informatics
  • Biostatistics

Background:

  • Disease staging is crucial for cancer research, particularly in administrative claims-based studies.
  • Claims databases often lack comprehensive disease stage information, necessitating algorithmic approaches.
  • No prior algorithm has been developed to categorize bladder cancer (BC) by stage in US healthcare claims data.

Purpose of the Study:

  • To develop and validate a claims-based algorithm for staging bladder cancer (BC) patients.
  • To categorize BC into non-muscle-invasive BC (NMIBC), muscle-invasive BC (MIBC), and locally advanced/metastatic urothelial carcinoma (la/mUC).

Main Methods:

  • A claims-based algorithm was developed using SEER-Medicare linked data.
  • The algorithm was validated against the SEER registry, with iterative parameter refinement.
  • Performance was assessed using agreement, Cohen's kappa (κ), specificity, positive predictive value (PPV), and negative predictive value (NPV).
  • Main Results:

    • The study included 15,484 BC patients: 71.0% NMIBC, 23.5% MIBC, and 5.5% la/mUC.
    • The optimized algorithm achieved 82.5% agreement with SEER data (κ = 0.58).
    • High PPVs were observed for NMIBC (87.0%) and MIBC (76.8%), with an excellent NPV for la/mUC (98.0%).

    Conclusions:

    • The developed claims-based algorithm is a viable tool for staging bladder cancer patients in research.
    • This algorithm can facilitate more accurate administrative claims-based studies on bladder cancer.